{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:43:45Z","timestamp":1762299825009,"version":"3.37.3"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The objective of this study was to review the results of umbilical cord drug screening in twins and triplets (multiples) to compare the detected drug(s) and\/or drug metabolite(s). Results that did not agree between multiples were considered mismatched and investigated. A retrospective analysis was conducted using de-identified data from a national reference laboratory, and results were compared with data from an academic medical center, where detailed medical chart review was performed. Umbilical cord was analyzed for stimulants, sedatives, opioids and other drugs and metabolites. For the reference laboratory dataset, 23.3% (n\u2009=\u2009844) of 3,616 umbilical cords from twins (n\u2009=\u20093,550) or triplets (n\u2009=\u200966) were positive for one or more drugs and\/or metabolites. Of these, mismatched results were identified for 37 sets of twins (2.1%) and no sets of triplets. The most frequent mismatches were found in opioids (n\u2009=\u200924), with morphine (n\u2009=\u20095) being the most mismatched of any single analyte in the panel. Mismatches for the marijuana metabolite 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (9-COOH-THC) in the reference laboratory dataset occurred in 6 of 737 sets of twins (0.8%) and no triplets. For the academic medical center dataset, 21.9% (n\u2009=\u200957) of 260 umbilical cords tested positive for one or more drugs and\/or metabolite(s). Of these, four mismatches (3.2%) were identified, including 9-COOH-THC (n\u2009=\u20092), phentermine (n\u2009=\u20091) and oxycodone (n\u2009=\u20091), all involving twins. All involved cases where the discrepant analyte was likely present in the negative twin but either slightly below the reporting cutoff threshold or failed analytical quality criteria. Mismatched results of umbilical cord drug screening occur in less than 4% of twins and most often occur when the analyte is slightly above the reporting cutoff in just one infant.<\/jats:p>","DOI":"10.1093\/jat\/bkab077","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T09:59:19Z","timestamp":1624528759000},"page":"611-618","source":"Crossref","is-referenced-by-count":2,"title":["Concordance of Umbilical Cord Drug Screening in Multiple Births: Experience from a Reference Laboratory and Academic Medical Center"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-2923","authenticated-orcid":false,"given":"Heather A","family":"Nelson","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Utah , 15 North Medical Drive East Ste. #1100, Salt Lake City, UT 84112, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly E","family":"Wood","sequence":"additional","affiliation":[{"name":"Stead Family Department of Pediatrics, University of Iowa Stead Family Children\u2019s Hospital , Iowa City, IA 52242, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3607-5878","authenticated-orcid":false,"given":"Gwendolyn A","family":"McMillin","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Utah , 15 North Medical Drive East Ste. #1100, Salt Lake City, UT 84112, USA"},{"name":"ARUP Institute for Clinical and Experimental Pathology , 500 Chipeta Way, Salt Lake City, UT 84108, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D","family":"Krasowski","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Iowa Hospitals & Clinics , Iowa City, IA 52242, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"article-title":"Substance use while pregnant and breastfeeding","volume-title":"National Institute on Drug Abuse","year":"2020","key":"2022071417284237700_R1"},{"key":"2022071417284237700_R2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/npp.2014.147","article-title":"Developmental consequences of fetal exposure to drugs: what we know and what we still must learn","volume":"40","author":"Ross","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"2022071417284237700_R3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.jp.7211416","article-title":"Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium","volume":"26","author":"Montgomery","year":"2006","journal-title":"Journal of Perinatology"},{"key":"2022071417284237700_R4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/jat\/bku061","article-title":"Meconium drug testing in multiple births in the USA","volume":"38","author":"Wood","year":"2014","journal-title":"Journal of Analytical Toxicology"},{"key":"2022071417284237700_R5","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1139\/y01-080","article-title":"The role of the placenta in variability of fetal exposure to cocaine and cannabinoids: a twin study","volume":"79","author":"Boskovic","year":"2001","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"2022071417284237700_R6","first-page":"318","article-title":"Multiple birth concordance of street drug assays of meconium analysis","volume":"37","author":"Lewis","year":"1995","journal-title":"Veterinary and Human Toxicology"},{"key":"2022071417284237700_R7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/jcp.2009.067595","article-title":"In utero drugs of abuse exposure testing for newborn twins","volume":"63","author":"Wang","year":"2010","journal-title":"Journal of Clinical Pathology"},{"key":"2022071417284237700_R8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/FTD.0b013e3182055f14","article-title":"Nicotine and metabolites in paired umbilical cord tissue and meconium specimens","volume":"33","author":"Marin","year":"2011","journal-title":"Therapeutic Drug Monitoring"},{"key":"2022071417284237700_R9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/jat\/34.8.498","article-title":"Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes","volume":"34","author":"Concheiro","year":"2010","journal-title":"Journal of Analytical Toxicology"},{"key":"2022071417284237700_R10","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/jat\/bky009","article-title":"Discordant umbilical cord drug testing results in monozygotic twins","volume":"42","author":"Alexander","year":"2018","journal-title":"Journal of Analytical Toxicology"},{"key":"2022071417284237700_R11","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.clinbiochem.2016.04.007","article-title":"Development of a liquid chromatography--tandem mass spectrometry method to address the increased utilization of umbilical cord in the assessment of in utero drug exposure","volume":"49","author":"Haglock-Adler","year":"2016","journal-title":"Clinical Biochemistry"},{"key":"2022071417284237700_R12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jat\/bkaa118","article-title":"Patterns of neonatal co-exposure to gabapentin and commonly abused drugs observed in umbilical cord tissue","volume":"45","author":"Okoye","year":"2021","journal-title":"Journal of Analytical Toxicology"},{"key":"2022071417284237700_R13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/FTD.0b013e3182a0d18c","article-title":"Detection of neonatal drug exposure using umbilical cord tissue and liquid chromatography time-of-flight mass spectrometry","volume":"36","author":"Marin","year":"2014","journal-title":"Therapeutic Drug Monitoring"},{"key":"2022071417284237700_R14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-4939-8823-5_20","article-title":"Detection of in utero cannabis exposure in umbilical cord tissue by a sensitive liquid chromatography-tandem mass spectrometry method","volume":"1872","author":"Wu","year":"2019","journal-title":"Methods in Molecular Biology"},{"key":"2022071417284237700_R15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/jat\/bkt052","article-title":"Detection of in utero marijuana exposure by GC\u2013MS, ultra-sensitive ELISA and LC\u2013TOF\u2013MS using umbilical cord tissue","volume":"37","author":"Chittamma","year":"2013","journal-title":"Journal of Analytical Toxicology"},{"key":"2022071417284237700_R16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.clinbiochem.2016.11.026","article-title":"Evaluating a switch from meconium to umbilical cord tissue for newborn drug testing: a retrospective study at an academic medical center","volume":"50","author":"Palmer","year":"2017","journal-title":"Clinical Biochemistry"},{"key":"2022071417284237700_R17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1542\/hpeds.2018-0256","article-title":"Risk-based newborn drug testing in a setting with a low prevalence of maternal drug use","volume":"9","author":"Wood","year":"2019","journal-title":"Hospital Pediatrics"},{"key":"2022071417284237700_R18","first-page":"1","article-title":"Births: final data for 2019","volume":"70","author":"Martin","year":"2021","journal-title":"National Vital Statistics Reports"},{"key":"2022071417284237700_R19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/FTD.0000000000000485","article-title":"Detection of drug-exposed newborns","volume":"40","author":"Wabuyele","year":"2018","journal-title":"Therapeutic Drug Monitoring"},{"key":"2022071417284237700_R20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.placenta.2019.12.001","article-title":"Umbilical cord as an analytical matrix \u2013 a technical note","volume":"90","author":"Price","year":"2020","journal-title":"Placenta"},{"key":"2022071417284237700_R21","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(03)14237-7","article-title":"Twinning","volume":"362","author":"Hall","year":"2003","journal-title":"Lancet"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkab077\/38858969\/bkab077.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/46\/6\/611\/44887116\/bkab077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/46\/6\/611\/44887116\/bkab077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T17:37:15Z","timestamp":1657820235000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/46\/6\/611\/6308719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,24]]},"published-print":{"date-parts":[[2022,7,14]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkab077","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"type":"print","value":"0146-4760"},{"type":"electronic","value":"1945-2403"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2021,6,24]]}}}